AU4170299A - Composition for the transdermal administration of non-steroidal anti-inflammatory drugs - Google Patents

Composition for the transdermal administration of non-steroidal anti-inflammatory drugs

Info

Publication number
AU4170299A
AU4170299A AU41702/99A AU4170299A AU4170299A AU 4170299 A AU4170299 A AU 4170299A AU 41702/99 A AU41702/99 A AU 41702/99A AU 4170299 A AU4170299 A AU 4170299A AU 4170299 A AU4170299 A AU 4170299A
Authority
AU
Australia
Prior art keywords
composition
steroidal anti
transdermal administration
inflammatory drugs
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41702/99A
Inventor
Jong Kun Choi
Mi Suk Choi
Cheol Moon
Je Phil Ryoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Corp
Original Assignee
LG Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Chemical Co Ltd filed Critical LG Chemical Co Ltd
Publication of AU4170299A publication Critical patent/AU4170299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU41702/99A 1998-06-02 1999-06-02 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs Abandoned AU4170299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9820378 1998-06-02
KR1019980020378A KR100294084B1 (en) 1998-06-02 1998-06-02 Composition for transdermal administration of non-steroid drugs and formulation containing same
PCT/KR1999/000272 WO1999062557A1 (en) 1998-06-02 1999-06-02 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs

Publications (1)

Publication Number Publication Date
AU4170299A true AU4170299A (en) 1999-12-20

Family

ID=19538135

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41702/99A Abandoned AU4170299A (en) 1998-06-02 1999-06-02 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs

Country Status (5)

Country Link
JP (1) JP2002516879A (en)
KR (1) KR100294084B1 (en)
CN (1) CN1304321A (en)
AU (1) AU4170299A (en)
WO (1) WO1999062557A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10032537A1 (en) * 2000-07-05 2002-01-31 Labtec Gmbh Dermal system containing 2- (3-benzophenyl) propionic acid
DE10049225A1 (en) * 2000-09-28 2002-04-11 Labtec Gmbh Dermal therapeutic system comprises diclofenac sodium in an acrylate copolymer matrix on a polyester web
KR20020037616A (en) * 2000-11-15 2002-05-22 서경배 Transdermal ketorolac formulation for increasing transdermal absorption of ketorolac
JP4969050B2 (en) * 2005-01-07 2012-07-04 ロート製薬株式会社 Topical skin preparation
CN103948571A (en) * 2006-07-18 2014-07-30 天津昕晨泰飞尔医药科技有限公司 Water-soluble ibuprofen prodrug with high skin penetration rate and positive charge
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
TR201009220A1 (en) * 2010-11-08 2012-05-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Topical pharmaceutical compositions of flurbiprofen and methyl salicylate.
CN103260613B (en) 2010-12-15 2015-01-14 欧拉泰克工业有限责任公司 3-methanesulfonylpropionitrile for treating inflammation and pain
AU2013271836B2 (en) * 2012-06-05 2018-03-01 Olatec Therapeutics Llc Method for treating skin inflammatory diseases
KR101882679B1 (en) * 2017-08-11 2018-07-27 이태완 Low Irritating of Transdermal Drug Delivery System for Anti-inflammatory and its Manufacturing Method
CN114191416B (en) * 2021-12-27 2023-09-15 河南省超亚医药器械有限公司 Transdermal drug delivery system for nonsteroidal anti-inflammatory drug and preparation process thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
JPH08509222A (en) * 1993-04-22 1996-10-01 ミネソタ マイニング アンド マニュファクチャリング カンパニー Transdermal anti-inflammatory composition
KR100215027B1 (en) * 1997-01-27 1999-08-16 성재갑 Composition for transdermal administration of steroid drugs and formulation containing same

Also Published As

Publication number Publication date
KR100294084B1 (en) 2001-09-22
KR20000000640A (en) 2000-01-15
CN1304321A (en) 2001-07-18
WO1999062557A1 (en) 1999-12-09
JP2002516879A (en) 2002-06-11

Similar Documents

Publication Publication Date Title
AU2001260414A1 (en) Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU762322C (en) Novel galenic formulations of meloxicam for oral administration
AU2109195A (en) Two-component device for the administration of drugs
BR9607862A (en) Film-forming pharmaceutical composition for transdermal administration
AU4209400A (en) Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
AU1585601A (en) Transdermal administration of huperzine
AU7375598A (en) Stable oral pharmaceutical dosage forms
IL131415A (en) Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them
AU2046900A (en) Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
AU4170299A (en) Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
AU3841499A (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
AU6565100A (en) Liquid pharmaceutical composition based on paracetamol
AU5460800A (en) Pharmaceutical transdermal compositions
AU5800896A (en) Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
AU3869399A (en) Transdermal administration of fenoldopam
AU2187699A (en) Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
AU7735798A (en) Pharmaceutical composition for oral administration
AUPP332898A0 (en) Pharmaceutical composition
AU5067498A (en) Biphenyl derivatives and drug composition
AU4145999A (en) Topical drug for the treatment of viral infections
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
AU7920198A (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
AUPN766496A0 (en) Method and composition for the potentiation of anti-inflammatory drugs
AU3444299A (en) Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase